glp-1 brain inflammation and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential A schematic representation of the

Methods : Using the TriNetX research network (accessed 3 November 2024), we conducted a retrospective cohort study of adults prescribed semaglutide ( n = 419,497) or tirzepatide ( n = 77,259) between January 2018 and October 2024

Alopecia Associated With The Use Of Semaglutide And Tirzepatide: A Disproportionality Analysis Using The FDA Adverse Event Continue reading Increased reporting odds of hair loss for: Semaglutide (199 cases) Tirzepatide (179 cases) No increased reporting odds of hair loss for: Liraglutide (20 cases) Dulaglutide (65 cases) Exenatide (6 cases) Lixisenatide (0 cases) There are a substantial number of reported cases of hair loss with the use of semaglutide and tirzepatide GLP-1 medications

10.2967/jnumed.108.059998 12 BrubakerP

We may recommend lab work and a body composition assessment to better understand your metabolic health

Let the water run gently down the glass